Support our Foundation of Myology project
On the initiative of FSHD Europe association, in which the AFM-Telethon is involved, a European network of clinical trials in FSH has just been created with the aim of connecting…
The 31st International Congress of the World Muscle Society (WMS) will take place from 29 September to 3 October 2026 in Hiroshima, Japan. Experts from the Institute of Myology will…
Platforms and Technology Units Since it was set up in 2007, the MyoLine human cell immortalisation platform has generated more than 200 human myoblast lines isolated from patients with more than 36 different diseases (DMD,…
Neuromuscular Investigation Center This laboratory is dedicated in particular to the morphological identification and characterisation of genetic neuromuscular diseases in children and adults. Histopathology Laboratory The Histopathology Laboratory is dedicated…
RESOURCES The Advances in research, Savoir & Comprendre leaflets published by AFM-Téléthon present the latest medical and scientific advances for a neuromuscular disease or a group of neuromuscular diseases. Updated every year,…
Laurence Tiennot-Herment, President of the Myology Institute Association, Sébastien Vial, Director General of Orléans University Hospital, and Sébastien Ringuedé, Vice-President in charge of the Training and University Life Committee at…
An international consortium of experts on facioscapulohumeral muscular dystrophy (FSHD) has compiled observations from patients diagnosed at a relatively advanced age: using clinical and biological data from a previous clinical…
The 30th International Congress of the World Muscle Society (WMS) will be held from 7 to 11 October 2025 in Vienna, Austria. The Institute of Myology will be well…
American clinicians, including Andrew Mammen, the researcher behind the first descriptions of immune-mediated necrotizing myopathy (IMNM), take stock of this pathology and highlight its atypical forms: after recalling the usual…
FSHD webinar series – Episode 4: “Clinical Trial Readiness” Wednesday 28 May 2025 – 16:00 – 17:00 Paris time Dr. Nicol Voermans & Ria de Haas, PhD (Radboud University Nijmegen…
FSHD webinar series – Episode 3: “Pediatric FSHD” Thursday 22 May 2025 – 16:00 – 17:00 Paris time Prof. Tracey Willis (Robert Jones and Agnes Hunt Orthopaedic and District Hospital…
FSHD webinar series – Episode 2: “International Clinical Care Guidelines” Thursday 15 May 2025 – 16:00 – 17:00 Paris time Dr. Teresinha Evangelista (Institute of Myology & Pitié Salpêtrière Hospital…
FSHD webinar series – Episode 1: “Genetic Diagnosis” Thursday 8 May 2025 – 16:00 – 17:00 Paris time Prof. Emiliano Giardina (University of Rome Tor Vergata, Italy) > + infos…
Matrin-3 deficiency can give rise to a form of amyotrophic lateral sclerosis (ALS) or distal myopathy with vocal cord paralysis (VCPDM). Russian clinicians report the clinical and biological data of…
The 29th International Congress of the World Muscle Society (WMS) will be held from 8 to 12 October 2024 in Prague, Czech Republic. The Institute of Myology will be very…
A French review has set out to provide an overview of the most emblematic late-onset myopathies (LOMs), those which may appear after the age of 50, and to identify the…
The initial results of the REACH Phase III placebo-controlled trial evaluating losmapimod in 260 adults with FSHD1 or FSHD2 over one year have just been announced by the Fulcrum Therapeutics…
The National Diagnostic and Care Protocol (PNDS) for facioscapulohumeral muscular dystrophy (FSHD) was published in France at the very end of 2021. A recent article published in the Journal of…
The 8th International Congress of Myology will be held in Paris from 22 to 25 April 2024. Here are the eight themes that experts from the Institute of Myology will…
An Iranian team has carried out an exhaustive review of the literature to determine the extent and nature of neuromuscular complications linked, directly or indirectly, with the COVID-19 pandemic: from…